Detailed information for compound 1323016

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 372.408 | Formula: C16H19F3N4OS
  • H donors: 2 H acceptors: 2 LogP: 3.61 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: CCC(NC(=O)c1cnn2c1NC(CC2C(F)(F)F)c1cccs1)C
  • InChi: 1S/C16H19F3N4OS/c1-3-9(2)21-15(24)10-8-20-23-13(16(17,18)19)7-11(22-14(10)23)12-5-4-6-25-12/h4-6,8-9,11,13,22H,3,7H2,1-2H3,(H,21,24)
  • InChiKey: UHBSRQUXZFSYLJ-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Aberrant vpr protein Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Plasmodium falciparum eukaryotic initiation factor 4A 0.0589 0.5 0.5
Echinococcus granulosus eukaryotic initiation factor 4A 0.0589 0.5 0.5
Echinococcus multilocularis eukaryotic initiation factor 4A 0.0589 0.5 0.5
Leishmania major eukaryotic initiation factor 4a, putative 0.0589 0.5 0.5
Echinococcus multilocularis eukaryotic initiation factor 4A III 0.0589 0.5 0.5
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0589 0.5 0.5
Trypanosoma cruzi Eukaryotic initiation factor 4A-1 0.0589 0.5 0.5
Treponema pallidum ATP-dependent RNA helicase 0.0589 0.5 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0589 0.5 0.5
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0589 0.5 0.5
Onchocerca volvulus Eukaryotic initiation factor 4A homolog 0.0589 0.5 0.5
Echinococcus granulosus eukaryotic initiation factor 4A III 0.0589 0.5 0.5
Trypanosoma brucei Eukaryotic initiation factor 4A-1 0.0589 0.5 0.5
Giardia lamblia Translation initiation factor eIF-4A, putative 0.0589 0.5 0.5
Leishmania major eukaryotic initiation factor 4a, putative 0.0589 0.5 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0589 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0589 0.5 0.5
Trichomonas vaginalis DEAD box ATP-dependent RNA helicase, putative 0.0589 0.5 0.5
Mycobacterium tuberculosis Probable cold-shock DeaD-box protein A homolog DeaD (ATP-dependent RNA helicase dead homolog) 0.0589 0.5 0.5
Schistosoma mansoni DEAD box ATP-dependent RNA helicase 0.0589 0.5 0.5
Toxoplasma gondii eukaryotic initiation factor-4A, putative 0.0589 0.5 0.5
Entamoeba histolytica DEAD/DEAH box helicase, putative 0.0589 0.5 0.5
Plasmodium vivax RNA helicase-1, putative 0.0589 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 8.9125 uM PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 28.1838 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 125.8925 uM PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.